Tumor-targeting oncolytic viruses engineered for glioblastoma immunotherapy

ABSTRACT: We report the development of an oncolytic virus engineered for enhanced targeting of tumor cells, increased safety, and greater antitumor efficacy through the expression of multiple transgenes that remodel the immunosuppressive GBM tumor microenvironment

ORGANISM(S): Mus musculus

PROVIDER: GSE244034 | GEO | 2025/07/14

REPOSITORIES: GEO